Bristol-Myers Squibb
BMY
#191
Rank
A$170.52 B
Marketcap
A$83.51
Share price
3.85%
Change (1 day)
19.41%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$5.29

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$5.17. In 2025 the company made an earnings per share (EPS) of A$5.02 an increase over its 2024 EPS that were of A-$6.42.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.295.33%
2025A$5.02-178.28%
2024A-$6.42-213.92%
2023A$5.6330.2%
2022A$4.33-6.04%
2021A$4.60-179.29%
2020A-$5.81-281.37%
2019A$3.20-27.21%
2018A$4.40
2016A$3.88175.26%
2015A$1.41-19.83%
2014A$1.76-22.44%
2013A$2.2634.48%
2012A$1.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.68 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.19 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.90-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.99-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.98 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$21.02 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.72-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.57 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.16-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.09 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK